{
    "wpid": "WP262",
    "organisms": ["Homo sapiens"],
    "description": "Latent membrane protein 1 (LMP1) of the Ebstein-Barr Virus (EBV) elicits its oncogenic effects through the activation of several downstream pathways such as Pi3K/akt, IRF4, and NFkB pathways.  Proteins on this pathway have targeted assays available via the [https://assays.cancer.gov/available_assays?wp_id=WP262 CPTAC Assay Portal]",
    "ontology-ids": [
        "PW:0001059",
        "PW:0001057"
    ],
    "last-edited": "2024-07-22",
    "title": "Ebstein-Barr virus LMP1 signaling",
    "authors": [
        "Thomas",
        "MartijnVanIersel",
        "MaintBot",
        "Khanspers",
        "Christine Chichester",
        "AlexanderPico",
        "Zari",
        "Mkutmon",
        "Roelod",
        "Eweitz"
    ],
    "revision": "r134385"
}